Safety and Efficacy of Secukinumab in Mild Psoriasis
Clinical trial NCT03131570 · COMPLETED
Trial details
- NCT number
- NCT03131570
- Sponsor
- James G. Krueger, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2020-01-08
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.